• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    GE HealthCare Technologies Inc. to Join the Nasdaq-100 Index® Beginning June 7, 2023

    5/30/23 8:00:00 PM ET
    $FISV
    $GEHC
    $NDAQ
    Business Services
    Consumer Discretionary
    Medical Electronics
    Health Care
    Get the next $FISV alert in real time by email

    NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that GE HealthCare Technologies Inc. (NASDAQ:GEHC), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX), the Nasdaq-100 Equal Weighted Index (NASDAQ:NDXE), and the Nasdaq-100 Ex-Tech Sector Index (NASDAQ:NDXX) prior to market open on Wednesday, June 7, 2023. GE HealthCare Technologies Inc. will replace Fiserv, Inc. (NASDAQ:FISV) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. Fiserv, Inc. will also be removed from the Nasdaq-100 ESG Index (NASDAQ:NDXESG) prior to market open on Wednesday, June 7, 2023.

    For more information about the company, go to https://www.gehealthcare.com/.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG -

    Media Contact: Camille Stafford, Nasdaq
    Issuer & Investor Contact:  Index Client Services, Nasdaq
      [email protected]

     



    Primary Logo

    Get the next $FISV alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $FISV
    $GEHC
    $NDAQ

    CompanyDatePrice TargetRatingAnalyst
    GE HealthCare Technologies Inc.
    $GEHC
    5/5/2025$73.00Sell → Neutral
    UBS
    Nasdaq Inc.
    $NDAQ
    4/17/2025$91.00Neutral → Buy
    Redburn Atlantic
    Nasdaq Inc.
    $NDAQ
    4/8/2025$74.00Overweight → Equal-Weight
    Morgan Stanley
    GE HealthCare Technologies Inc.
    $GEHC
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    Nasdaq Inc.
    $NDAQ
    1/8/2025$80.00 → $98.00Hold → Buy
    Deutsche Bank
    GE HealthCare Technologies Inc.
    $GEHC
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    Nasdaq Inc.
    $NDAQ
    11/25/2024Outperform
    William Blair
    Nasdaq Inc.
    $NDAQ
    10/14/2024$82.00Mkt Perform → Outperform
    Raymond James
    More analyst ratings

    $FISV
    $GEHC
    $NDAQ
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nasdaq Halts Bowen Acquisition Corp.

      NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading was halted on July 15, 2025 in Bowen Acquisition Corp. at 17:45:19 Eastern Time for additional information requested from the company. The last sale price of the company's securities was: Ordinary shares (NASDAQ:BOWN) $9.19Rights (NASDAQ:BOWNR) $0.2252Units (NASDAQ:BOWNU) $13.02 Trading will remain halted until Bowen Acquisition Corp. has fully satisfied Nasdaq's request for additional information. For news and additional information about the company, please contact the company directly or check under the company's symbol using InfoQuotesSM on the Nasdaq® Web site. For more inform

      7/16/25 4:05:00 PM ET
      $BOWN
      $NDAQ
      Package Goods/Cosmetics
      Consumer Discretionary
      Investment Bankers/Brokers/Service
      Finance
    • Delisting of Securities from The Nasdaq Stock Market

      NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.'s securities were suspended on March 5, 2025 and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock, rights, and units of Aquaron Acquisition Corp. Aquaron Acquisition Corp.'s securities were suspended on March 7, 2025 and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock, warrants, and rights of Bannix Acquisition Corp. Bannix Acquisition Corp.'s securities were suspended on March 17, 2025 an

      7/11/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 30, 2025

      NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 30, 2025, short interest in 3,257 Nasdaq Global MarketSM securities totaled 14,138,758,851 shares compared with 13,689,191,607 shares in 3,207 Global Market issues reported for the prior settlement date of June 13, 2025. The mid-June short interest represents 2.59 days compared with 2.32 days for the prior reporting period. Short interest in 1,636 securities on The Nasdaq Capital MarketSM totaled 2,790,159,938 shares at the end of the settlement date of June 30, 2025, compared with 2,687,331,325 shares in 1,642 securities for the previous reporting period. This represents a 1.00 day average daily volume;

      7/10/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $FISV
    $GEHC
    $NDAQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Zollar Alfred W bought $203,970 worth of shares (2,542 units at $80.24), increasing direct ownership by 5% to 49,293 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      11/14/24 4:29:16 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

      4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

      5/2/24 6:00:38 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • Torgeby Johan bought $705,880 worth of shares (14,000 units at $50.42), increasing direct ownership by 165% to 22,466 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      10/25/23 4:02:10 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $FISV
    $GEHC
    $NDAQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, CIO Peterson Bradley J covered exercise/tax liability with 10,986 shares and sold $1,022,716 worth of shares (11,508 units at $88.87), decreasing direct ownership by 17% to 111,035 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      7/3/25 1:11:01 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • EVP, CSO Skule Jeremy sold $187,703 worth of shares (2,105 units at $89.17), decreasing direct ownership by 2% to 94,656 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      7/3/25 1:09:05 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Pres. Capital Access Platforms Griggs Pc Nelson covered exercise/tax liability with 11,484 shares, decreasing direct ownership by 6% to 195,921 units (SEC Form 4)

      4 - NASDAQ, INC. (0001120193) (Issuer)

      7/3/25 1:05:10 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $FISV
    $GEHC
    $NDAQ
    SEC Filings

    See more
    • SEC Form 8-K filed by Nasdaq Inc.

      8-K - NASDAQ, INC. (0001120193) (Filer)

      6/16/25 4:00:28 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • GE HealthCare Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

      6/9/25 4:07:02 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.

      SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      6/6/25 11:26:39 AM ET
      $GEHC
      Medical Electronics
      Health Care

    $FISV
    $GEHC
    $NDAQ
    Leadership Updates

    Live Leadership Updates

    See more
    • Nasdaq Welcomes 142 IPOs in the First Half of 2025

      Highest volume of listings and capital raise in the first half of the year since 2021 Maintained leadership in switches - crossed $3 trillion in market value transferred since 2005 Driving smart policy reforms to improve regulatory processes for public companies NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) announced today that in the first half of 2025, it welcomed 142 listings (IPOs), raising a total of $19.2 billion. A total of 83 operating companies and 59 SPACs listed on Nasdaq during the first six months of 2025, representing an 86% win-rate of Nasdaq-eligible listings in the U.S. market, and extending Nasdaq's leadership to 46 consecutive quarters. In add

      7/1/25 8:05:00 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Nasdaq Announces Results from 2025 Annual Meeting of Shareholders

      All 12 Nominated Directors Elected Nasdaq Board Re-elects Adena T. Friedman as Chair of the Board NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (NASDAQ:NDAQ) shareholders elected all nominated directors at the company's Annual Meeting of Shareholders on Wednesday, June 11, 2025. All directors will serve one-year terms. The elected board members are: Melissa M. Arnoldi, EVP and General Manager for Business Solutions, AT&T Inc.Charlene T. Begley, Retired SVP and CIO, General Electric CompanyAdena T. Friedman, Chair and CEO, NasdaqEssa Kazim, Governor, Dubai International Financial CentreThomas A. Kloet, Retired CEO and Executive Director, TMX Group LimitedKathryn A. Koch, Presi

      6/16/25 4:30:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

      BOCA RATON, Fla., June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announces the Company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025. Mr. Montagut brings over 25 years of senior leadership experience in the pharmaceutical sector, with a solid track record of driving growth and executing strategic transformation across glob

      6/2/25 8:00:00 AM ET
      $GEHC
      $LNTH
      Medical Electronics
      Health Care
      Biotechnology: In Vitro & In Vivo Diagnostic Substances

    $FISV
    $GEHC
    $NDAQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

      SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

      11/12/24 3:53:01 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

      SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

      11/12/24 12:53:28 PM ET
      $GEHC
      Medical Electronics
      Health Care
    • SEC Form SC 13G filed by Nasdaq Inc.

      SC 13G - NASDAQ, INC. (0001120193) (Subject)

      11/8/24 10:52:39 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $FISV
    $GEHC
    $NDAQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • GE HealthCare upgraded by UBS with a new price target

      UBS upgraded GE HealthCare from Sell to Neutral and set a new price target of $73.00

      5/5/25 8:34:55 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • NASDAQ upgraded by Redburn Atlantic with a new price target

      Redburn Atlantic upgraded NASDAQ from Neutral to Buy and set a new price target of $91.00

      4/17/25 8:27:31 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance
    • NASDAQ downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded NASDAQ from Overweight to Equal-Weight and set a new price target of $74.00

      4/8/25 9:21:41 AM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance

    $FISV
    $GEHC
    $NDAQ
    Financials

    Live finance-specific insights

    See more
    • GE HealthCare to announce second quarter 2025 results on July 30, 2025

      GE HealthCare (NASDAQ:GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical techno

      7/7/25 8:00:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • GE HealthCare announces cash dividend for second quarter of 2025

      The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 payable on August 15, 2025 to all shareholders of record as of July 25, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more

      7/1/25 8:34:00 AM ET
      $GEHC
      Medical Electronics
      Health Care
    • Nasdaq to Hold Second Quarter 2025 Investor Conference Call

      NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) has scheduled its second quarter 2025 financial results announcement.  Who:Nasdaq's CEO, CFO, and additional members of its senior management team    What:Review Nasdaq's second quarter 2025 financial results    When:Thursday, July 24, 2025  Results Call: 8:00 AM Eastern    Senior management will be available for questions from the investment community following prepared remarks. All participants can access the conference via webcast through the Nasdaq Investor Relations website at http://ir.nasdaq.com/. Note: The press release and results presentation for the second quarter 2025 results will be posted on the Nasdaq Investo

      6/26/25 4:05:00 PM ET
      $NDAQ
      Investment Bankers/Brokers/Service
      Finance